TYVASO DPI
Make room for proven efficacy with direct-to-lung delivery2,3
TYVASO DPI provides your patients with a simple-to-use treatment option for PAH.1
Just 1 breath
per cartridge2
Low inspiratory effort required, with a normal, deep breath4,5
High patient
satisfaction3
Designed for medication dispersal in the first 0.5 seconds at a low flow rate of ~20 L/min, delivering a consistent dose to the distal airways1,4-6
No cleaning or refrigeration required7
Titration with TYVASO DPI2
Titration schedules may vary based on tolerability. The target maintenance dose is usually 48 to 64 mcg per session. If the prescribed dose is higher than 80 mcg per treatment session, more than 1 cartridge will be needed per session.2
BREEZE OEP data showed that patients could titrate to high doses, with one patient titrating up to 176 mcg with TYVASO DPI (comparable to ~33 breaths from the nebulizer), 4x daily.6
Dose comparison6
Patients can transition between either TYVASO device.
*Based on extrapolation of lower doses assuming linearity.
Treatment sessions can be scheduled around daily activities, approximately every 4 waking hours.2
Taking a dose is as simple as:
JUST ONE BREATH—
OPEN, LOAD, INHALE
TYVASO DPI was well tolerated2
See the BREEZE safety and tolerability data for more information.
LEARN MORE
